These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 20308387)

  • 1. Plasmodium vivax susceptibility to ferroquine.
    Leimanis ML; Jaidee A; Sriprawat K; Kaewpongsri S; Suwanarusk R; Barends M; Phyo AP; Russell B; Renia L; Nosten F
    Antimicrob Agents Chemother; 2010 May; 54(5):2228-30. PubMed ID: 20308387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The antimalarial ferroquine: from bench to clinic.
    Biot C; Nosten F; Fraisse L; Ter-Minassian D; Khalife J; Dive D
    Parasite; 2011 Aug; 18(3):207-14. PubMed ID: 21894260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ex vivo drug susceptibility of ferroquine against chloroquine-resistant isolates of Plasmodium falciparum and P. vivax.
    Marfurt J; Chalfein F; Prayoga P; Wabiser F; Kenangalem E; Piera KA; Machunter B; Tjitra E; Anstey NM; Price RN
    Antimicrob Agents Chemother; 2011 Sep; 55(9):4461-4. PubMed ID: 21730116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of ferroquine (SSR 97193) against Plasmodium falciparum isolates from the Thai-Burmese border.
    Barends M; Jaidee A; Khaohirun N; Singhasivanon P; Nosten F
    Malar J; 2007 Jun; 6():81. PubMed ID: 17597537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of ferroquine (SAR97193) is independent of chloroquine resistance in Plasmodium falciparum.
    Kreidenweiss A; Kremsner PG; Dietz K; Mordmüller B
    Am J Trop Med Hyg; 2006 Dec; 75(6):1178-81. PubMed ID: 17172389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of ferroquine against artemisinin-based combination therapy (ACT)-resistant Plasmodium falciparum isolates from Cambodia.
    Mairet-Khedim M; Nardella F; Khim N; Kim S; Kloeung N; Ke S; Kauy C; Eam R; Khean C; Pellet A; Leboulleux D; Leang R; Ringwald P; Barale JC; Leroy D; Menard D; Witkowski B
    J Antimicrob Chemother; 2019 Nov; 74(11):3240-3244. PubMed ID: 31518407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contrasting ex vivo efficacies of "reversed chloroquine" compounds in chloroquine-resistant Plasmodium falciparum and P. vivax isolates.
    Wirjanata G; Sebayang BF; Chalfein F; Prayoga ; Handayuni I; Noviyanti R; Kenangalem E; Poespoprodjo JR; Burgess SJ; Peyton DH; Price RN; Marfurt J
    Antimicrob Agents Chemother; 2015 Sep; 59(9):5721-6. PubMed ID: 26149984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ferrocene conjugates of chloroquine and other antimalarials: the development of ferroquine, a new antimalarial.
    Dive D; Biot C
    ChemMedChem; 2008 Mar; 3(3):383-91. PubMed ID: 17806092
    [No Abstract]   [Full Text] [Related]  

  • 9. In vitro susceptibility to a new antimalarial organometallic analogue, ferroquine, of Plasmodium falciparum isolates from the Haut-Ogooué region of Gabon.
    Atteke C; Ndong JM; Aubouy A; Maciejewski L; Brocard J; Lébibi J; Deloron P
    J Antimicrob Chemother; 2003 Apr; 51(4):1021-4. PubMed ID: 12654770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ferroquine and its derivatives: new generation of antimalarial agents.
    Wani WA; Jameel E; Baig U; Mumtazuddin S; Hun LT
    Eur J Med Chem; 2015 Aug; 101():534-51. PubMed ID: 26188909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel 4-aminoquinoline analogs highly active against the blood and sexual stages of Plasmodium in vivo and in vitro.
    Sáenz FE; Mutka T; Udenze K; Oduola AM; Kyle DE
    Antimicrob Agents Chemother; 2012 Sep; 56(9):4685-92. PubMed ID: 22710117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extended blood stage sensitivity profiles of
    Christensen P; Cinzah R; Suwanarusk R; Chua ACY; Kaneko O; Kyle DE; Aung HL; Matheson J; Bifani P; Rénia L; Cook GM; Snounou G; Russell B
    Antimicrob Agents Chemother; 2024 May; 68(5):e0028024. PubMed ID: 38587391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibility of Plasmodium falciparum to artemisinins and Plasmodium vivax to chloroquine in Phuoc Chien Commune, Ninh Thuan Province, south-central Vietnam.
    Phong NC; Chavchich M; Quang HH; San NN; Birrell GW; Chuang I; Martin NJ; Manh ND; Edstein MD
    Malar J; 2019 Jan; 18(1):10. PubMed ID: 30654808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of Plasmodium vivax crt-o Is Related to Parasite Stage but Not Ex Vivo Chloroquine Susceptibility.
    Pava Z; Handayuni I; Wirjanata G; To S; Trianty L; Noviyanti R; Poespoprodjo JR; Auburn S; Price RN; Marfurt J
    Antimicrob Agents Chemother; 2016 Jan; 60(1):361-7. PubMed ID: 26525783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probing the distinct chemosensitivity of Plasmodium vivax liver stage parasites and demonstration of 8-aminoquinoline radical cure activity in vitro.
    Maher SP; Vantaux A; Chaumeau V; Chua ACY; Cooper CA; Andolina C; Péneau J; Rouillier M; Rizopoulos Z; Phal S; Piv E; Vong C; Phen S; Chhin C; Tat B; Ouk S; Doeurk B; Kim S; Suriyakan S; Kittiphanakun P; Awuku NA; Conway AJ; Jiang RHY; Russell B; Bifani P; Campo B; Nosten F; Witkowski B; Kyle DE
    Sci Rep; 2021 Oct; 11(1):19905. PubMed ID: 34620901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring of clinical efficacy and in vitro sensitivity of Plasmodium vivax to chloroquine in area along Thai Myanmar border during 2009-2010.
    Muhamad P; Ruengweerayut R; Chacharoenkul W; Rungsihirunrat K; Na-Bangchang K
    Malar J; 2011 Feb; 10():44. PubMed ID: 21324161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasmodium vivax drug resistance genes; Pvmdr1 and Pvcrt-o polymorphisms in relation to chloroquine sensitivity from a malaria endemic area of Thailand.
    Rungsihirunrat K; Muhamad P; Chaijaroenkul W; Kuesap J; Na-Bangchang K
    Korean J Parasitol; 2015 Feb; 53(1):43-9. PubMed ID: 25748708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasmodium falciparum and Plasmodium vivax Demonstrate Contrasting Chloroquine Resistance Reversal Phenotypes.
    Wirjanata G; Handayuni I; Prayoga P; Leonardo L; Apriyanti D; Trianty L; Wandosa R; Gobay B; Kenangalem E; Poespoprodjo JR; Noviyanti R; Kyle DE; Cheng Q; Price RN; Marfurt J
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28533239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chloroquine-resistant Plasmodium vivax, Brazilian Amazon.
    de Santana Filho FS; Arcanjo AR; Chehuan YM; Costa MR; Martinez-Espinosa FE; Vieira JL; Barbosa Md; Alecrim WD; Alecrim Md
    Emerg Infect Dis; 2007 Jul; 13(7):1125-6. PubMed ID: 18214203
    [No Abstract]   [Full Text] [Related]  

  • 20. In vitro susceptibility of Plasmodium vivax to antimalarials in Colombia.
    Fernández D; Segura C; Arboleda M; Garavito G; Blair S; Pabón A
    Antimicrob Agents Chemother; 2014 Nov; 58(11):6354-9. PubMed ID: 25114141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.